ECONOMIC ANALYSES OF TRASTUZUMAB BIOSIMILAR FOR TREATMENT OF PATIENTS WITH HER2-POSITIVE BREAST CANCER FROM A BRAZILIAN PRIVATE HEALTHCARE PERSPECTIVE

被引：0
|
作者：
Tanaka, S. [1 ]
Suri, G. [2 ]
Despiegel, N. [3 ]
Nascimendo, C. [1 ]
Aratangy, G. [1 ]
机构：
[1] Amgen Inc, Sao Paulo, Brazil
[2] Amgen Inc, London, England
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN147
引用
收藏
页码：S449 / S449
页数：1
相关论文
共 50 条
  • [1] Trastuzumab Biosimilar for Patients with HER2-positive Breast Cancer and Stomach Cancer Effective and economical Treatment with a new Trastuzumab Biosimilar
    不详
    BREAST CARE, 2019, 14 (04) : 260 - 261
  • [2] The Global Need for a Trastuzumab Biosimilar for Patients With HER2-Positive Breast Cancer
    Blackwell, Kimberly
    Gligorov, Joseph
    Jacobs, Ira
    Twelves, Chris
    CLINICAL BREAST CANCER, 2018, 18 (02) : 95 - 113
  • [3] Trastuzumab Biosimilar for HER2-positive Breast Cancer and Stomach Cancer Effective and economical Treatment with a new Trastuzumab Biosimilar
    不详
    BREAST CARE, 2019, 14 (05) : 338 - 339
  • [4] ABP 980: promising trastuzumab biosimilar for HER2-positive breast cancer
    Paplomata, Elisavet
    Nahta, Rita
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (03) : 335 - 341
  • [5] Trastuzumab biosimilar for HER2-positive breast and gastric carcinoma
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (09) : 482 - 483
  • [6] Trastuzumab deruxtecan in the treatment of adult patients with HER2-positive breast cancer
    Kufel-Grabowska, Joanna
    ONCOLOGY IN CLINICAL PRACTICE, 2023, 19 (05): : 377 - 381
  • [7] An economic evaluation of trastuzumab as adjuvant treatment of early HER2-positive breast cancer patients in Colombia
    Antonio Buendia, Jefferson
    Vallejos, Carlos
    Pichon-Riviere, Andres
    BIOMEDICA, 2013, 33 (03): : 411 - 417
  • [8] Real-World Study of Adjuvant Biosimilar Trastuzumab-dkst for HER2-Positive Breast Cancer Treatment in a Brazilian Population
    Gagliato, Debora
    Reinert, Tomas
    Rocha, Claudio
    Tavares, Monique
    Pimentel, Samio
    Fuzita, William
    Araujo, Marcia
    Matias, Danielli
    Aleixo, Sabina
    Franca, Bruno
    Magaton, Erida
    Brito, Natalia
    Cardoso, Ana Carolina
    Castilho, Vivienne
    ONCOLOGY AND THERAPY, 2024, 12 (03) : 437 - 449
  • [9] Role of subcutaneous formulation of trastuzumab in the treatment of patients with HER2-positive breast cancer
    Melichar, Bohuslav
    Studentova, Hana
    Kalabova, Hana
    Vitaskova, Denisa
    IMMUNOTHERAPY, 2014, 6 (07) : 811 - 819
  • [10] Trastuzumab emtansine in the treatment of HER2-positive metastatic breast cancer in Japanese patients
    Sawaki, Masataka
    BREAST CANCER-TARGETS AND THERAPY, 2014, 6 : 37 - 41
12345